Reconstruction of the 1918 influenza virus: Unexpected rewards from the past

mBio

Volumn 3, Issue 5, 2012, Pages

  Taubenberger, Jeffery K ^a   Baltimore, David ^b   Doherty, Peter C ^c   Markel, Howard ^d   Morens, David M ^a   Webster, Robert G ^e   Wilson, Ian A ^f  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868360156     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00201-12     Document Type: Review

References (61)

1. Johnson NP, Mueller J. 2002. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull. Hist. Med. 76: 105-115.
2. Taubenberger JK, Morens DM. 2006. 1918 influenza: the mother of all pandemics. Emerg. Infect. Dis. 12:15-22.
3. Francis T, Jr. 1953. Influenza: the newe acquayantance. Ann. Intern. Med. 39:203-221.
4. Reid AH, Fanning TG, Hultin JV, Taubenberger JK. 1999. Origin and evolutionof the 1918 "Spanish" influenza virus hemagglutinin gene. Proc. Natl. Acad. Sci. U. S. A. 96:1651-1656.
5. Taubenberger JK, Hultin JV, Morens DM. 2007. Discovery and characterization of the 1918 pandemic influenza virus in historical context. An-tivir. Ther. 12:581-591.
6. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG. 1997. Initial genetic characterization of the 1918 "Spanish" influenza virus. Science 275:1793-1796.
7. Taubenberger JK, et al. 2005. Characterization of the 1918 influenza virus polymerase genes. Nature 437:889-893.
8. Tumpey TM, et al. 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310:77-80.
9. Fauci AS, Gerberding JL. 5 October 2005, posting date. Unmasking the 1918 influenza virus: an important step toward pandemic influenza preparedness. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD. http://www.niaid.nih.gov/news /newsreleases/2005/Pages/0510state.aspx.
10. Centers for Disease Control and Prevention. 2009. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. U.S. Government Printing Office, Washington, DC.
11. Morens DM, Taubenberger JK, Fauci AS. 2009. The persistent legacy of the 1918 influenza virus. N. Engl. J. Med. 361:225-229.
12. Easterbrook JD, et al. 2011. Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infection. Influenza Other Respi. Viruses 5:198-205.
13. Medina RA, et al. 2010. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nat. Commun. 1:28. http://dx.doi.org/10.1038/ncomms1026.
14. Pearce MB, et al. 2012. Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets. J. Virol. 86:7118-7125.
15. Wei CJ, et al. 2010. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2:24ra21. http://dx.doi.org/10.1126/scitranslmed.3000799.
16. Xu R, et al. 2010. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328:357-360.
17. Yu X, et al. 2008. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455:532-536.
18. Ekiert DC, et al. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
19. Fleishman SJ, et al. 2011. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 332:816-821.
20. Nabel GJ, Fauci AS. 2010. Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine. Nat. Med. 16: 1389-1391.
21. Tan GS, et al. 2012. A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J. Virol. 86:6179-6188.
22. Greenbaum BD, Levine AJ, Bhanot G, Rabadan R. 2008. Patterns of evolution and host gene mimicry in influenza and other RNA viruses. PLoS Pathog. 4:e1000079. http://dx.doi.org/10.1371/journal.ppat.1000079.
23. Rabadan R, Levine AJ, Robins H. 2006. Comparison of avian and human influenza A viruses revealsa mutational biasonthe viral genomes. J. Virol. 80:11887-11891.
24. Smith GJ, et al. 2009. Dating the emergence of pandemic influenza viruses. Proc. Natl. Acad. Sci. U.S.A. 106:11709-11712.
25. Taubenberger JK, Kash JC. 2010. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7:440-451.
26. Qi L, et al. 2012. Analysis by single gene reassortment demonstrates that the 1918 influenza virus is functionally compatible with a low pathogenicity avian influenza virus in mice. J. Virol. 86:9211-9220.
27. Morens DM, Taubenberger JK. 2011. Pandemic influenza: certain uncertainties. Rev. Med. Virol. 21:262-284.
28. Dugan VG, et al. 2008. The evolutionary genetics and emergence of avian influenza virusesinwild birds. PLoS Pathog. 4: e1000076. http://dx.doi.org/10.1371/journal.ppat.1000076.
29. Nelson MI, et al. 2008. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog. 4:e1000012. http://dx.doi.org/10.1371/journal.ppat.1000012.
30. Obenauer JC, et al. 2006. Large-scale sequence analysis of avian influenza isolates. Science 311:1576-1580.
31. Rambaut A, et al. 2008. The genomic and epidemiological dynamics of human influenza A virus. Nature 453:615-619.
32. Holmes EC, et al. 2005. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol. 3:e300. http://dx.doi.org/10.1371/journal.pbio.0030300.
33. Garten RJ, et al. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201.
34. Memoli MJ, et al. 2009. An early "classical" swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. Virology 393:338-345.
35. Kobasa D, et al. 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445:319-323.
36. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. 2007. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3:1414-1421. http://dx.doi.org/10.1371/journal.ppat.0030141.
37. Jagger BW, et al. 2010. The PB2-E627K mutation attenuates viruses containing the 2009 H1N1 influenza pandemic polymerase. mBio 1(1): e00067-10. http://dx.doi.org/10.1128/mBio.00067-10.
38. Kash JC, et al. 2006. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443:578-581.
39. Kobasa D, et al. 2004. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431:703-707.
40. Pappas C, et al. 2008. Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc. Natl. Acad. Sci. U. S. A. 105:3064-3069.
41. Qi L, et al. 2011. The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding. Virology 412:426-434.
42. Watanabe T, et al. 2009. Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets. Proc. Natl. Acad. Sci. U. S. A. 106:588-592.
43. Dunham EJ, et al. 2009. Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. J. Virol. 83: 5485-5494.
44. Mehle A, Doudna JA. 2009. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc. Natl. Acad. Sci. U. S. A. 106: 21312-21316.
45. Mehle A, Dugan VG, Taubenberger JK, Doudna JA. 2012. Reassortment and mutation of the avian influenza virus polymerase PA subunit overcome species barriers. J. Virol. 86:1750-1757.
46. Tumpey TM, et al. 2007. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315:655-659.
47. Van Hoeven N, et al. 2009. Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. J. Virol. 83: 2851-2861.
48. Herfst S, et al. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534-1541.
49. Imai M, et al. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486: 420-428.
50. Stevens J, et al. 2006. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 355:1143-1155.
51. Stevens J, et al. 2006. Structure and receptor specificity of the hemagglu-tinin from an H5N1 influenza virus. Science 312:404-410.
52. Stevens J, et al. 2004. Structure of the uncleaved human H1 hemaggluti-nin from the extinct 1918 influenza virus. Science 303:1866-1870.
53. Russell CA, et al. 2012. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 336:1541-1547.
54. Sheng ZM, et al. 2011. Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak. Proc. Natl. Acad. Sci. U. S. A. 108: 16416-16421.
55. Kuiken T, Taubenberger JK. 2008. The pathology of human influenza revisited. Vaccine 26:D59-D66.
56. Morens DM, Taubenberger JK, Fauci AS. 2008. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198:962-970.
57. Kash JC, et al. 2011. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses. mBio 2(5):e00172-11. http://dx.doi.org/10.1128/mBio.00172-11.
58. Ballinger MN, Standiford TJ. 2010. Postinfluenza bacterial pneumonia: host defenses gone awry. J. Interferon Cytokine Res. 30:643-652.
59. Nakamura S, Davis KM, Weiser JN. 2011. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J. Clin. Invest. 121:3657-3665.
60. Jain S, Benoit SR, Skarbinski J, Bramley AM, Finelli L. 2012. Influenza-associated pneumonia among hospitalized patients with 2009 pandemic influenza A (H1N1) virus-United States, 2009. Clin. Infect. Dis. 54: 1221-1229.
61. Jagger BW, et al. 2012. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337: 199-204.